[Pubmed] Programming of metabolic and autoimmune diseases in canine and feline: linkage to the gut microbiome

[RSS-Bot]

Microb Pathog. 2023 Oct 30:106436. doi: 10.1016/j.micpath.2023.106436. Online ahead of print.

ABSTRACT

Metabolic and autoimmune disorders have long represented challenging health problems because of their growing prevalence in companion animals. The gut microbiome, made up of trillions of microorganisms, is implicated in multiple physiological and pathological processes. Similar to human beings, the complicated microbiome harbored in the gut of canines and felines emerges as a key factor determining a wide range of normal and disease conditions. Evidence accumulated from recent findings on canine and feline research uncovered that the gut microbiome is actively involved in host metabolism and immunity. Notably, the composition, abundance, activity, and metabolites of the gut microbiome are all elements that shape clinical outcomes concerning metabolism and immune function. This review highlights the implications of the gut microbiome for metabolic disorders (obesity, diabetes, and hepatic lipidosis) and autoimmune diseases (inflammatory bowel disease, osteoarthritis, asthma, and myasthenia gravis) in canine and feline animals, providing novel strategies and therapeutic targets for the prevention and treatment of pet diseases.

PMID:37913827 | DOI:10.1016/j.micpath.2023.106436


Source: https://pubmed.ncbi.nlm.nih.gov/3791382 ... t6+86293ac